For the Savvy investor, opportunities can often arise, even during periods of market downturns. Top investors see these times as opportunities to acquire high-potential assets at lower prices, with the expectation of significant growth once the market regains its momentum. It's a strategy that's been utilized by many, seeking to capitalize on the cyclical nature of markets and the inevitable rebounds that follow downward trends.
These four stocks, which have a focus on drone technology, biopharmaceuticals, entertainment networks, and sustainable energy solutions, might have the adaptability, innovation, and alignment with sectors that are expected to grow. Let's take a closer look at a few stocks that are turning heads.
Epazz, Inc. (OTC: EPAZ) emerges as a striking contender for those seeking stocks with strong potential for a rebound. As recent market fluctuations temporarily impact EPAZ's stock value, a closer analysis of the company's moves, innovation, and industry recognition paints a picture of resilience and promise, making it a prime candidate for investors on the lookout for well-positioned stocks trading at a discount.
EPAZ's recent patent victory, its third for the revolutionary ZenaDrone 1000 Drone equipped with AI Predictive capabilities, echoes the company's commitment to innovation. With official patent issuance forthcoming, EPAZ secures not only the unique design of the ZenaDrone 1000 but also claims on its application. This marks a significant step forward in the company's pursuit to build a comprehensive drone patent portfolio, a move that can potentially attract larger industry players.
The partnerships underscore EPAZ's robust expansion plans. As ZenaDrone, Inc. ramps up production of over 30 drones, including a visionary venture 'Drone as a Service' in Ireland and a joint venture with NightSun, LLC, the foundation for a broad market presence strengthens.
An additional testament to EPAZ's potential is the letter of support received from the U.S. Air Force. This recognition highlights the company's burgeoning foothold in the defense sector, adding another layer of opportunity to its already diversified growth strategy.
In the realm of rebound stocks, it's crucial to discern between momentary setbacks and long-term potential. The ZenaDrone 1000's AI advancements signal a transformative potential across various industries like agriculture, oil and gas, wildfire prevention, and civil engineering. This presents investors with an opportunity to enter at a lower price point before the company's initiatives and technological advancements drive a rebound.
CEO Dr. Shaun Passley's unwavering confidence in the company's future showcases his commitment to delivering exceptional products to both Irish and American markets. This vision, coupled with EPAZ's relentless pursuit of innovation, positions the company as an attractive rebound stock candidate.
In a market landscape rife with fluctuations, it's essential to keep the bigger picture in mind. EPAZ's story embodies the essence of rebound stocks—a chance to invest in a promising company at a discount. As the market tides change, EPAZ stands poised to transform temporary market sentiment into an opportunity for shrewd investors to capitalize on future growth potential.
American Battery Technology Company (OTC: ABML), formerly known as American Battery Metals Corporation, is uniquely positioned to supply domestically sourced battery metals through its three divisions: lithium-ion battery recycling, primary battery metal extraction technologies, and primary resource development. The company has developed a clean technology platform to provide critical and strategic battery metals for electric vehicles, electrical grid storage, and consumer electronics industries, following an ESG-principled approach that emphasizes ethical and environmentally sustainable sourcing.
On August 1, 2023, ABML announced the finalization of the design and approval for its third drill program to advance its Tonopah Flats Lithium Project. This project is recognized as one of the largest known lithium resources in the United States. The drill program's goal is to move from inferred resource status to a commercial reserve through core infill drilling and material sampling at greater depths. This step marks a significant advancement in the exploration of this resource, with a focus on depths of up to 1,500 feet.
CEO Ryan Melsert expressed enthusiasm for the approval, highlighting the underexplored potential of the Tonopah Flats Lithium Project. He emphasized that only 65% of the claims have been explored to date, and the resource remains open both at the surface and in depth. ABML aims to fully evaluate the resource by conducting a comprehensive drill program that includes sampling depths of up to 1,500 feet.
The Tonopah Flats Lithium Project covers 517 unpatented lode claims across 10,340 acres, with ABML controlling all mining lode claims and mineral rights. The project's significance was underscored by a third-party Qualified Person (QP) audited SK-1300 compliant maiden Inferred Resource Report, which estimated approximately 15.8 million tons of economically accessible lithium on a carbonate equivalent basis (LCE).
As ABML progresses with its third drill program, it plans to collect samples from up to 5,000 feet of drilling across multiple drill holes. This effort aims to enhance geologic understanding and confidence for future modeling of the deposit, particularly in relation to lithium mineralization.
ABML's commitment to lithium extraction and processing is exemplified by its collaboration with DuPont and the University of Nevada, Reno, which led to substantial grant awards from the Department of Energy (DOE). These grants support the validation, commercialization, and scale-up of critical battery-grade lithium resources, positioning ABML as a key player in domestic battery metal supply.
ABML's efforts align with the growing demand for battery metals and the push toward sustainable energy solutions, making it an intriguing prospect for investors seeking exposure to the clean energy sector.
Humanigen, Inc. (OTC: HGEN) Recent market movements may have cast a temporary shadow over Humanigen's stock, but a nuanced examination of the company's direction, research efforts, and forward-looking initiatives might suggest the potential for a possible rebound.
Humanigen is a clinical-stage biopharmaceutical firm that has centered its efforts on lenzilumab, a pioneering antibody designed to neutralize granulocyte-macrophage colony-stimulating factor (GM-CSF). With a particular focus on addressing chronic myelomonocytic leukemia and acute graft versus host disease (aGvHD), Humanigen's commitment to advancing medical solutions is noteworthy. Additionally, the company's exploration of lenzilumab's potential to manage toxicities linked to CAR-T therapy demonstrates proactive foresight.
Recently, HGEN announced the launch of the RATinG trial—a Phase 2/3 study conducted by IMPACT across prominent UK centers. This trial aims to assess lenzilumab's efficacy as an early treatment for high-risk acute GvHD following stem cell transplantation. The anticipated interim assessment in 2024 adds a layer of intrigue to the journey.
The collaboration between Humanigen, IMPACT, and the US Magic Consortium, as acknowledged by Professor Adrian Bloor, underscores the collective dedication to advancing medical research. The trial's expansion across 18 IMPACT treatment hubs in the UK bolsters its potential impact on patient outcomes.
The focus on lenzilumab as a potential remedy for aGvHD exemplifies Humanigen's dedication to addressing critical medical challenges. By targeting the immune signaling of GM-CSF, the company's approach holds promise for mitigating the inflammatory cascade linked to aGvHD.
Under the guidance of Dr. Cameron Durrant, Humanigen's leadership underscores the company's commitment to improving patient well-being. This commitment resonates throughout the medical landscape, positioning Humanigen as a participant with meaningful potential in the biopharmaceutical domain.
In the midst of market fluctuations, the spotlight shifts to Rino International Corp. (OTC: RINO), now known as JOIN Entertainment Holdings Inc. (JOIN TV). Recent developments and a company-wide shift in focus herald a fresh direction, making JOIN TV a noteworthy contender for investors seeking opportunities amidst market shifts.
JOIN TV's transformation stems from a successful FINRA-approved reverse takeover merger (RTO) and a change of control. The company's direction shift aligns with a new era, propelled by name change approval from the State of Utah. Additionally, a FINRA application for corporate name and trade symbol changes is in progress, reflecting the company's commitment to its new trajectory.
As a prominent North American Entertainment Network, JOIN TV is at the forefront of distribution and revenue solutions for Over-the-Top (OTT) platforms worldwide. The unveiling of the "JOIN" brand marks the evolution of the company into a media entity. This F.A.S.T. (Free Ad-Supported Television) channel network redefines the streaming experience by offering a unique blend of live television and on-demand content, setting it apart from subscription-based models. JOIN TV's commitment to universal access is evident through its free content distribution approach, making entertainment accessible globally.
With over 1.4 billion Smart TVs worldwide, JOIN TV's potential to captivate audiences on a global scale is substantial. The company's collaborative approach involves content sharing agreements anchored in revenue sharing models, ensuring a diverse programming lineup to cater to various preferences. The partnership with prominent industry players underscores JOIN TV's commitment to offering unparalleled content options.
In sync with the evolving landscape of advertising, JOIN TV is poised to embrace the rise of Free Ad Streaming Television (F.A.S.T. TV). Projections indicate a surge in U.S. ad revenue generated by FAST services, indicating potential for robust revenue generation.
The accessibility of JOIN TV as an app on Smart TVs, phones, and tablets ensures a seamless user experience. This adaptability empowers viewers to engage with their favorite content at their convenience.
JOIN Entertainment Holdings Inc., under its JOIN TV banner, is set to launch its exciting offerings in the fall of 2023. As market dynamics evolve, JOIN TV emerges as a contender with the potential for resurgence, capturing the essence of opportunity amid market shifts.
Disclaimers:CapitalGainsReport (CGR) is not operated by a licensed broker, a dealer, or a registered investment adviser. This content is for informational purposes only and is not intended to be investment advice. The Private Securities Litigation Reform Act of 1995 provides investors a safe harbor in regard to forward-looking statements. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions, or future events or performance are not statements of historical fact may be forward looking statements. Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as projects, foresee, expects, will, anticipates, estimates, believes, understands, or that by statements indicating certain actions & quote; may, could, or might occur. Understand there is no guarantee past performance will be indicative of future results. Investing in micro-cap and growth securities is highly speculative and carries an extremely high degree of risk. It is possible that an investors investment may be lost or impaired due to the speculative nature of the companies profiled. CapitalGainsReport (CGR) is owned by RazorPitch Inc. and has been retained by Epazz Inc. to assist in the production and distribution of content. 'CGR' is responsible for the production and distribution of this content. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. This content is for informational purposes only, you should not construe any such information or other material as legal, tax, investment, financial, or other advice. Nothing contained in this article constitutes a solicitation, recommendation, endorsement, or offer by CapitalGainsReport/RazorPitch or any third party service provider to buy or sell any securities or other financial instruments. All content in this article is information of a general nature and does not address the circumstances of any particular individual or entity. Nothing in this article constitutes professional and/or financial advice, nor does any information in the article constitute a comprehensive or complete statement of the matters discussed or the law relating thereto. CGR/RazorPitch is not a fiduciary by virtue of any persons use of or access to this content. Please visit CapitalGainsReport.com/Disclaimer for full disclaimer.